Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Long delays in referring patients to a urologist increase the risk of death after radical cystectomy for bladder cancer, according to a Canadian study.
The finding has two important implications for patients with bladder cancer. First, by assessing levels of TERT mRNA (which more directly determines ...
I went from bladder cancer to kidney cancer, went through radiation for 45 days,” explains Cassulo. The recent study from The National Institute of ...
FORT MYERS, Fla.- Nearly 50,000 people in the U.S. are living with pancreaticcancer at any given time. Pancreatic cancer also accounts for about 7 ...
“The prognosis for pancreatic cancer is typically poor, and it is critical to expand the range of treatment options available to these patients.”.
Oncolytics Biotech's REOLYSIN receives Orphan Drug Designation for treatment of pancreatic cancer -News-Medical.net
Oncolytics Bio's lead product an Orphan Drug for pancreatic cancer (ONCY) - Seeking Alpha (registration)
Entrectinib demonstrated prolonged stable disease in two patients: one with ALK-positive NSCLC and one with ROS1-positive pancreatic cancer.
New research suggests that patients recovering from bowel cancer surgery may be at a higher risk of relapse if their blood shows an immune ...
For the first time scientists from Umeå University show the importance of DNA damage in fine tuning of our innate immune system and hence the ability ...
Alzheimer's disease may involve the immune system, and researchers might have figured out how to pinpoint the origin of a cancer that has spread ...
... on the cancer cell surface, thus potentially exposing the cancer cells and allowing the immune systemto attack the malignant cells more efficiently.".
Preclinical data show that SEA-CD40 stimulates the immune system to fight cancer. “We are pleased to advance our SEA-CD40 immuno-oncology ...
Patients in the first part of the study were treated with 1 cycle of PROSTVAC-V/TRICOM, a vaccine that primes the body's immune system to respond to ...
Dr Carroll said the immunosuppressant drugs don't directly cause cancer but they suppress the body's immune system and its ability to rid itself of ...
Science Daily Cancer News
After studying cancer survivors and their family caregivers, researchers conclude that the period between the final cancer treatment and first post-treatment checkup may be an ideal time for the entire household to jumpstart a healthy lifestyle.
Chinese researchers have developed a simple, rapid device for detecting volatile organic compounds on the breath, demonstrating potential for early cancer detection.
Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trials, researchers report. Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is currently effective against the disease.
Tambahkan Komentar